These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 20220840)

  • 1. Targeting early infection to prevent HIV-1 mucosal transmission.
    Haase AT
    Nature; 2010 Mar; 464(7286):217-23. PubMed ID: 20220840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the landscape of HIV prevention.
    Haase AT
    Am J Reprod Immunol; 2014 Jun; 71(6):490-4. PubMed ID: 24702688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immune dysfunction in AIDS pathogenesis.
    Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
    AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immunity, HIV transmission, and AIDS.
    Miller CJ; McGhee JR; Gardner MB
    Lab Invest; 1993 Feb; 68(2):129-45. PubMed ID: 8441249
    [No Abstract]   [Full Text] [Related]  

  • 5. Mucosal Vaccination for Prevention of HIV Infection and AIDS.
    Aldovini A
    Curr HIV Res; 2016; 14(3):247-59. PubMed ID: 26957199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonhuman primate models for cell-associated simian immunodeficiency virus transmission: the need to better understand the complexity of HIV mucosal transmission.
    Bernard-Stoecklin S; Gommet C; Cavarelli M; Le Grand R
    J Infect Dis; 2014 Dec; 210 Suppl 3():S660-6. PubMed ID: 25414421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T lymphocytes in AIDS pathogenesis: lessons to be learned from the macaque model of simian immunodeficiency virus infection.
    Geretti AM; Hulskotte E; Osterhaus AD
    J Gen Virol; 1998 Mar; 79 ( Pt 3)():415-21. PubMed ID: 9519818
    [No Abstract]   [Full Text] [Related]  

  • 8. Mucosal immunology of HIV infection.
    Xu H; Wang X; Veazey RS
    Immunol Rev; 2013 Jul; 254(1):10-33. PubMed ID: 23772612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early events in sexual transmission of HIV and SIV and opportunities for interventions.
    Haase AT
    Annu Rev Med; 2011; 62():127-39. PubMed ID: 21054171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS and mucosal immunity: usefulness of the SIV macaque model of genital mucosal transmission.
    Miller C; Gardner MB
    J Acquir Immune Defic Syndr (1988); 1991; 4(12):1169-72. PubMed ID: 1941523
    [No Abstract]   [Full Text] [Related]  

  • 11. Perils at mucosal front lines for HIV and SIV and their hosts.
    Haase AT
    Nat Rev Immunol; 2005 Oct; 5(10):783-92. PubMed ID: 16200081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection.
    Pope M; Haase AT
    Nat Med; 2003 Jul; 9(7):847-52. PubMed ID: 12835704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction: Back to basics: mucosal immunity and novel HIV vaccine concepts.
    Broliden K; Haase AT; Ahuja SK; Shearer GM; Andersson J
    J Intern Med; 2009 Jan; 265(1):5-17. PubMed ID: 19093956
    [No Abstract]   [Full Text] [Related]  

  • 14. Mucosal transmission of virulent and avirulent lentiviruses in macaques.
    Pauza CD; Horejsh D; Wallace M
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S83-7. PubMed ID: 9581890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing paradigms for an HIV vaccine.
    Schultz AM
    Adv Exp Med Biol; 1996; 397():79-90. PubMed ID: 8718586
    [No Abstract]   [Full Text] [Related]  

  • 16. Relative transmissibility of an R5 clade C simian-human immunodeficiency virus across different mucosae in macaques parallels the relative risks of sexual HIV-1 transmission in humans via different routes.
    Chenine AL; Siddappa NB; Kramer VG; Sciaranghella G; Rasmussen RA; Lee SJ; Santosuosso M; Poznansky MC; Velu V; Amara RR; Souder C; Anderson DC; Villinger F; Else JG; Novembre FJ; Strobert E; O'Neil SP; Secor WE; Ruprecht RM
    J Infect Dis; 2010 Apr; 201(8):1155-63. PubMed ID: 20214475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to mucosal transmission of immunodeficiency viruses.
    Keele BF; Estes JD
    Blood; 2011 Jul; 118(4):839-46. PubMed ID: 21555745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of nonhuman primate models to develop mucosal AIDS vaccines.
    Genescà M; Miller CJ
    Curr HIV/AIDS Rep; 2010 Feb; 7(1):19-27. PubMed ID: 20425054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates.
    Kim CN; Adams DR; Bashirian S; Butera S; Folks TM; Otten RA
    J Med Primatol; 2006 Aug; 35(4-5):210-6. PubMed ID: 16872284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.
    Baba TW; Liska V; Hofmann-Lehmann R; Vlasak J; Xu W; Ayehunie S; Cavacini LA; Posner MR; Katinger H; Stiegler G; Bernacky BJ; Rizvi TA; Schmidt R; Hill LR; Keeling ME; Lu Y; Wright JE; Chou TC; Ruprecht RM
    Nat Med; 2000 Feb; 6(2):200-6. PubMed ID: 10655110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.